BIANCONI, MARISTELLA
 Distribuzione geografica
Continente #
NA - Nord America 3.095
EU - Europa 1.428
AS - Asia 1.203
SA - Sud America 375
AF - Africa 104
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 1
Totale 6.210
Nazione #
US - Stati Uniti d'America 3.039
SG - Singapore 404
BR - Brasile 309
IT - Italia 307
VN - Vietnam 224
CN - Cina 220
RU - Federazione Russa 205
UA - Ucraina 200
DE - Germania 129
SE - Svezia 129
TR - Turchia 111
IE - Irlanda 107
FI - Finlandia 82
DK - Danimarca 75
HK - Hong Kong 74
FR - Francia 69
GB - Regno Unito 63
KR - Corea 42
CI - Costa d'Avorio 38
IN - India 36
MA - Marocco 28
BD - Bangladesh 27
CA - Canada 26
MX - Messico 21
AR - Argentina 20
ZA - Sudafrica 17
JP - Giappone 14
NL - Olanda 14
ES - Italia 13
CO - Colombia 11
EC - Ecuador 10
ID - Indonesia 10
BE - Belgio 8
CL - Cile 8
PL - Polonia 8
VE - Venezuela 8
IQ - Iraq 7
MY - Malesia 7
DZ - Algeria 6
TN - Tunisia 5
EU - Europa 4
PK - Pakistan 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
HN - Honduras 3
KE - Kenya 3
LT - Lituania 3
RS - Serbia 3
SA - Arabia Saudita 3
SC - Seychelles 3
AT - Austria 2
AZ - Azerbaigian 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GR - Grecia 2
JO - Giordania 2
KZ - Kazakistan 2
PE - Perù 2
PH - Filippine 2
PY - Paraguay 2
UZ - Uzbekistan 2
AO - Angola 1
BN - Brunei Darussalam 1
BO - Bolivia 1
EG - Egitto 1
IM - Isola di Man 1
JM - Giamaica 1
KG - Kirghizistan 1
LB - Libano 1
MD - Moldavia 1
MT - Malta 1
NP - Nepal 1
OM - Oman 1
PS - Palestinian Territory 1
TH - Thailandia 1
TV - Tuvalu 1
Totale 6.210
Città #
Ashburn 537
Singapore 252
Chandler 236
Fairfield 217
Jacksonville 207
Dallas 154
San Jose 138
Wilmington 137
Dublin 107
Seattle 98
Centro 96
Boardman 94
New York 84
Woodbridge 83
Houston 78
Ho Chi Minh City 72
Hong Kong 70
Ann Arbor 69
Council Bluffs 68
Beijing 61
Cambridge 59
Hanoi 58
Des Moines 51
Los Angeles 51
Moscow 48
Lawrence 43
Princeton 43
San Mateo 43
Turin 43
Lauterbourg 38
Abidjan 37
The Dalles 36
Munich 29
Helsinki 23
Turku 21
Orem 20
São Paulo 20
Milan 18
London 17
San Diego 17
Hefei 15
Tokyo 14
Atlanta 13
Buffalo 13
Chennai 13
Chicago 13
Johannesburg 11
Pune 10
Rio de Janeiro 10
Columbus 9
Frankfurt am Main 9
Izmir 9
Montreal 9
Santa Clara 9
Stockholm 9
Brasília 8
Brussels 8
Paris 8
Amsterdam 7
Belo Horizonte 7
Da Nang 7
Manchester 7
Poplar 7
Cagliari 6
Denver 6
Miano 6
Norwalk 6
Porto Alegre 6
San Francisco 6
Santiago 6
Shanghai 6
Warsaw 6
Wuxi 6
Brooklyn 5
Bến Tre 5
Campinas 5
Curitiba 5
Dhaka 5
Fortaleza 5
Guangzhou 5
Guayaquil 5
Kilburn 5
Mexico City 5
Rome 5
Washington 5
Wuhan 5
Biên Hòa 4
Bogotá 4
Bắc Giang 4
Duque de Caxias 4
Fayetteville 4
Goiânia 4
Guarulhos 4
Haiphong 4
Madrid 4
Montevideo 4
Mumbai 4
Santo André 4
Toronto 4
Ancona 3
Totale 3.978
Nome #
Mismatch repair deficiency may affect clinical outcome through immune response activation in metastatic gastric cancer patients receiving first-line chemotherapy 222
Immunotherapy in genitourinary cancers: Where are we going? 209
The role of micro-RNAs in hepatocellular carcinoma: from molecular biology to treatment 198
The role of Aspirin as antitumoral agent for heavily pre-treated metastatic colorectal cancer patients receiving capecitabine monotherapy. BMC Cancer 195
Angiogenesis genotyping and clinical outcome during regorafenib treatment in metastatic colorectal cancer patients 194
Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients. 194
A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer. 184
The correlation between LDH serum levels and clinical outcome in advanced biliary tract cancer patients treated with first line chemotherapy 174
Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE-2 Study 170
Il profilo angiogenico nel carcinoma renale metastatico: implicazioni prognostiche e terapeutiche 166
Lactate Dehydrogenase in Hepatocellular Carcinoma: Something Old, Something New 164
Phosphorylated AKT and MAPK expression in primary tumours and in corresponding metastases and clinical outcome in colorectal cancer patients receiving irinotecan-cetuximab. 161
Neutrophil‑to‑lymphocyte ratio may be associated with the outcome in patients with prostate cancer 160
VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: the ALICE-1 study 158
CANCER STEM CELL GENETIC PROFILE AS PREDICTOR OF RELAPSE IN RADICALLY RESECTED COLORECTAL CANCER 157
Prognostic clinical factors in pretreated colorectal cancer patients receiving regorafenib: Implications for clinical management 156
Tumor VEGF expression correlates with tumor stage and identifies prognostically different groups in clear cell renal cell carcinoma patients 156
Adjuvant treatment after surgical resection 156
Tumor angiogenesis genotyping and efficacy of first-line chemotherapy in metastatic gastric cancer patients. 155
Contemporary best practice in the management of urothelial carcinomas of the renal pelvis and ureter 152
Panitumumab for the treatment of metastatic colorectal cancer: A review 149
Clinical evidence for three distinct gastric cancer subtypes: time for a new approach. 144
Dalotuzumab, a recombinant humanized mAb targeted against IGFR1 for the treatment of cancer. 142
The role of LDH serum levels in predicting global outcome in HCC patients undergoing TACE: implications for clinical management. 142
The "angiogenetic ladder", step-wise angiogenesis inhibition in metastatic colorectal cancer 140
Beyond RAS: the role of epidermal growth factor receptor (EGFR) and its network in the prediction of clinical outcome during anti-EGFR treatment in colorectal cancer patients 140
VEGF and VEGFR polymorphisms affect clinical outcome in advanced renal cell carcinoma patients receiving first-line sunitinib 138
Role of vascular endothelial growth factor (VEGF) and VEGF-R genotyping in guiding the metastatic process in pT4a resected gastric cancer patients. 137
Prognostic Value for Incidental Antihypertensive Therapy With β-Blockers in Metastatic Colorectal Cancer 134
Molecular biomarkers of resistance to anti-EGFR treatment in metastatic colorectal cancer, from classical to innovation. 133
Angiogenesis genotyping in the selection of first-line treatment with either sunitinib or pazopanib for advanced renal cell carcinoma 132
Three drugs vs two drugs first-line chemotherapy regimen in advanced gastric cancer patients: a retrospective analysis 129
The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: implications for clinical management 128
Role of β4 integrin in HER-3-negative, K-RAS wild-type metastatic colorectal tumors receiving cetuximab. 126
The role of tumor vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) polymorphisms in the prediction of clinical outcome for advanced renal cell carcinoma patients receiving first-line sunitinib 125
Selected gastrointestinal cancer presentations from the American Society of Clinical Oncology annual meeting 2013 in review: It is not about the destination, it is about the journey 118
The Tower of Babel of liver metastases from colorectal cancer: Are we ready for one language? 111
Protracted low doses of temozolomide for the treatment of patients with recurrent glioblastoma: A phase II study. 109
VEGF expression and response to sunitinib in patients with metastatic clear cell renal cell carcinoma 103
The Role of Aspirin as Antitumoral Agent for Heavily Pretreated Patients With Metastatic Colorectal Cancer Receiving Capecitabine Monotherapy 100
Selected news from the 2014 Genitourinary Cancers Symposium: Translating novel strategies into clinical practice 91
State of the art and future perspectives for the use of insulin-like growth factor receptor 1 (IGF-1R) targeted treatment strategies in solid tumors. 86
Tumor VEGF expression correlates with tumor stage and identifies prognostically different groups in clear cell renal cell carcinoma 68
Totale 6.306
Categoria #
all - tutte 27.362
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.362


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022370 35 92 4 5 2 19 21 22 18 53 29 70
2022/2023727 53 98 59 48 47 114 1 38 166 3 83 17
2023/2024364 61 2 29 45 54 93 6 11 1 6 8 48
2024/2025833 112 74 10 12 47 29 120 32 139 62 109 87
2025/20262.337 158 226 166 236 293 170 357 199 165 212 55 100
2026/202765 65 0 0 0 0 0 0 0 0 0 0 0
Totale 6.306